Syneos Health Appoints Two New Independent Directors
18 janv. 2022 06h16 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has appointed two new...
Syneos Health to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 janv. 2022 09h06 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health to Present at Upcoming Investor Conferences
11 nov. 2021 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the Company is scheduled...
Syneos Health Reports Third Quarter 2021 Results
03 nov. 2021 06h16 HE
|
Syneos Health, Inc.
Highlights Third quarter revenue of $1,348.2 million increased 22.7% year-over-year.Clinical Solutions net new business awards of $1,353.8 million for the third quarter, representing year-over-year...
Syneos Health Schedules Third Quarter 2021 Earnings Call for Wednesday, November 3rd, 2021
19 oct. 2021 09h32 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2021 financial...
Syneos Health Acquires RxDataScience
06 oct. 2021 08h16 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of...
Syneos Health Acquires StudyKIK
14 sept. 2021 17h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of StudyKIK, a...
Syneos Health and Ride Health Partner to Improve Clinical Trial Recruitment and Retention
09 sept. 2021 09h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic...
Novan Engages Syneos Health as Commercial Solutions Provider for SB206
08 sept. 2021 09h00 HE
|
Novan, Inc.
– Company targeting New Drug Application (NDA) for SB206 in Q3 2022, following recent clinically and statistically significant topline efficacy results from a pivotal Phase 3 B-SIMPLE4 trial in...
Syneos Health Reports Second Quarter 2021 Results
09 août 2021 06h12 HE
|
Syneos Health, Inc.
Highlights Second quarter revenue of $1,282.6 million, increased 6.1% sequentially and 26.6% year-over-year.Clinical Solutions net new business awards of $1,436.2 million for the second quarter,...